Abstract
We present a case of tuberculous peritonitis in a woman with rheumatoid arthritis (RA), treated with adalimumab, and we review the association between anti-tumour necrosis factor (anti-TNF) therapy and tuberculosis. There have been only 2 case reports of peritoneal tuberculosis associated with anti-TNF and only 1 with adalimumab.
MeSH terms
-
Adalimumab
-
Aged
-
Antibiotics, Antitubercular / therapeutic use
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Antirheumatic Agents / adverse effects*
-
Antirheumatic Agents / therapeutic use
-
Arthritis, Rheumatoid / drug therapy*
-
Female
-
Humans
-
Isoniazid / therapeutic use
-
Mycobacterium tuberculosis / isolation & purification
-
Opportunistic Infections / diagnosis
-
Opportunistic Infections / drug therapy
-
Opportunistic Infections / etiology*
-
Peritonitis, Tuberculous / diagnosis
-
Peritonitis, Tuberculous / drug therapy
-
Peritonitis, Tuberculous / etiology*
-
Pyrazinamide / therapeutic use
-
Rifampin / therapeutic use
Substances
-
Antibiotics, Antitubercular
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antirheumatic Agents
-
Pyrazinamide
-
Adalimumab
-
Isoniazid
-
Rifampin